Literature DB >> 29725401

Rapid progression of a granulocyte colony-stimulating factor-producing liver tumor metastasized from esophagogastric junction cancer: A case report and literature review.

Sojun Hoshimoto1, Nobuo Hoshi2, Iwao Ozawa1, Moriaki Tomikawa1, Hirofumi Shirakawa1, Takeshi Fujita1, Saho Wakamatsu2, Sayuri Hoshi2, Kaoru Hirabayashi2, Shoichi Hishinuma1, Yoshiro Ogata1.   

Abstract

The current study presents the case of a 72-year-old woman with a rapidly enlarged liver metastasis from esophagogastric junction (EGJ) cancer, accompanied by progressive leukocytosis (47,680/µl) and elevated serum granulocyte colony-stimulating factor (G-CSF; 779 pg/ml). The patient underwent right hemihepatectomy 26 months after a total gastrectomy. On the seventh post-operative day the patient's leukocyte count and serum G-CSF level decreased to 4,280/µl and ≤19.5 pg/ml, respectively. Histologically, the lesion was a well to moderately differentiated adenocarcinoma similar to the primary lesion. Therefore, this tumor was clinically diagnosed as a G-CSF-producing liver metastasis from EGJ cancer, although immunohistochemical staining for G-CSF was negative. A right pulmonary nodule detected simultaneously with the hepatic mass was resected four months following the hepatectomy and was diagnosed as a pulmonary metastasis. The patient's leukocyte count was normal at the time of her initial surgery for EGJ cancer, and her clinical course varied for different metastatic sites. The liver metastasis was accompanied by progressive leukocytosis and elevated serum G-CSF and demonstrated rapid tumor growth during a six-month period, whereas the non-G-CSF-producing pulmonary metastasis grew slowly during the same period. In addition 21 reported cases of G-CSF-producing upper gastrointestinal tract cancer were reviewed to elucidate the clinicopathological features of this disease.

Entities:  

Keywords:  esophagogastric junction cancer; granulocyte colony-stimulating factor; leukocytosis; upper gastrointestinal tract cancer

Year:  2018        PMID: 29725401      PMCID: PMC5920498          DOI: 10.3892/ol.2018.8144

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  29 in total

1.  Gastric adenosquamous carcinoma producing granulocyte-colony stimulating factor.

Authors:  Kazuya Endo; Shunji Kohnoe; Takeshi Okamura; Masaru Haraguchi; Eisuke Adachi; Yasushi Toh; Hideo Baba; Yoshihiko Maehara
Journal:  Gastric Cancer       Date:  2005       Impact factor: 7.370

2.  Establishment of specific monoclonal antibodies against recombinant human granulocyte colony-stimulating factor (hG-CSF) and their application for immunoperoxidase staining of paraffin-embedded sections.

Authors:  K Shimamura; J Fujimoto; J Hata; A Akatsuka; Y Ueyama; T Watanabe; N Tamaoki
Journal:  J Histochem Cytochem       Date:  1990-02       Impact factor: 2.479

3.  G-CSF supplementation with chemotherapy can promote revascularization and subsequent tumor regrowth: prevention by a CXCR4 antagonist.

Authors:  Tali Voloshin; Svetlana Gingis-Velitski; Rotem Bril; Liat Benayoun; Michal Munster; Chloe Milsom; Shan Man; Robert S Kerbel; Yuval Shaked
Journal:  Blood       Date:  2011-06-17       Impact factor: 22.113

4.  Response to chemotherapy in a case of gastric adenocarcinoma producing granulocyte colony-stimulating factor.

Authors:  Hiroki Mori; Tomoyoshi Shibuya; Taro Osada; Tomohiro Kodani; Yoshie Higashihara; Nobuko Serizawa; Junko Kato; Akihito Nagahara; Tatsuo Ogihara; Sumio Watanabe
Journal:  Med Sci Monit       Date:  2010-10

5.  Etiology and outcome of extreme leukocytosis in 758 nonhematologic cancer patients: a retrospective, single-institution study.

Authors:  John M Granger; Dimitrios P Kontoyiannis
Journal:  Cancer       Date:  2009-09-01       Impact factor: 6.860

6.  Granulocyte colony-stimulating factor-producing esophageal squamous cell carcinoma following chemoradiotherapy and bone marrow transplantation for acute lymphoblastic leukemia.

Authors:  Shuhei Mayanagi; Masahiro Niihara; Hironobu Goto; Tomoya Yokota; Hiroyuki Tabuse; Hiroshi Yasui; Hirofumi Ogawa; Tetsuo Nishimura; Kimihide Kusafuka; Yasuhiro Tsubosa
Journal:  Esophagus       Date:  2013-08-28       Impact factor: 4.230

7.  Radical esophagectomy for a 92-year-old woman with granulocyte colony-stimulating factor-producing esophageal squamous cell carcinoma: a case report.

Authors:  Mari Kitani; Yukinori Yamagata; Asami Tanabe; Kouichi Yagi; Susumu Aikou; Takashi Kiyokawa; Masato Nishida; Hiroharu Yamashita; Kazuhiko Mori; Sachiyo Nomura; Yasuyuki Seto
Journal:  World J Surg Oncol       Date:  2016-10-13       Impact factor: 2.754

8.  Choroidal metastasis from granulocyte colony-stimulating factor-producing esophageal squamous cell carcinoma: a case report.

Authors:  Shuichi Fukuda; Yoshinori Fujiwara; Hiroshi Mishima; Tomoko Wakasa; Hitoshi Hanamoto; Keisuke Inoue; Kotaro Kitani; Hajime Ishikawa; Masanori Tsujie; Masao Yukawa; Kaoru Okajima; Yoshio Ohta; Masatoshi Inoue
Journal:  Clin Case Rep       Date:  2017-02-23

9.  Autonomous production of granulocyte-colony stimulating factor in tumour xenografts associated with leukocytosis.

Authors:  Y Katoh; M Nakamura; Y Ohnishi; K Shimamura; Y Ueyama; N Tamaoki
Journal:  Br J Cancer       Date:  1993-10       Impact factor: 7.640

10.  The significance of G-CSF expression and myeloid-derived suppressor cells in the chemoresistance of uterine cervical cancer.

Authors:  Mahiru Kawano; Seiji Mabuchi; Yuri Matsumoto; Tomoyuki Sasano; Ryoko Takahashi; Hiromasa Kuroda; Katsumi Kozasa; Kae Hashimoto; Aki Isobe; Kenjiro Sawada; Toshimitsu Hamasaki; Eiichi Morii; Tadashi Kimura
Journal:  Sci Rep       Date:  2015-12-15       Impact factor: 4.379

View more
  4 in total

1.  Leukocytosis Associated with Esophageal Squamous Cell Carcinoma as a Predictor of Poor Prognosis - A Case Report and Review of Literature.

Authors:  Apoorva Jayarangaiah; Pramod Theetha Kariyanna; Tanuj Chokshi; Maya Srinivasan; Seline Asun; Michael Ashamalla; Irini Youssef; Samy I McFarlane
Journal:  Am J Med Case Rep       Date:  2019-01-22

2.  Paraneoplastic Leukemoid Reaction in Gastroesophageal Junction Adenocarcinoma: A Case Report.

Authors:  Kevin Wei-Lun Chang; Lai Lai Kwok; Manish K Rana; Sapna Patel; Thomas Birris
Journal:  Am J Case Rep       Date:  2020-01-31

3.  Favorable response to pembrolizumab in granulocyte colony-stimulating factor-producing upper urinary tract urothelial carcinoma.

Authors:  Hiroki Takeda; Ryuji Matsumoto; Emi Takakuwa; Kanta Hori; Takuya Moriguchi; Shuhei Yamada; Hiroshi Kikuchi; Takahiro Osawa; Takashige Abe; Nobuo Shinohara
Journal:  IJU Case Rep       Date:  2021-12-17

Review 4.  G-CSF in tumors: Aggressiveness, tumor microenvironment and immune cell regulation.

Authors:  Ioannis Karagiannidis; Eralda Salataj; Erika Said Abu Egal; Ellen J Beswick
Journal:  Cytokine       Date:  2021-03-04       Impact factor: 3.926

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.